Patents by Inventor Adam Henk

Adam Henk has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20220106279
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: July 6, 2021
    Publication date: April 7, 2022
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee G. Wulf, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20190084949
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: November 16, 2018
    Publication date: March 21, 2019
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Wulf, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • Class of mu-opioid receptor agonists
    Patent number: 10183919
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Grant
    Filed: March 12, 2015
    Date of Patent: January 22, 2019
    Assignee: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Gassaway, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • A NEW CLASS OF MU-OPIOID RECEPTOR AGONISTS
    Publication number: 20170217913
    Abstract: The present invention provides a compound having the structure: or a pharmaceutically acceptable salt or ester thereof.
    Type: Application
    Filed: March 12, 2015
    Publication date: August 3, 2017
    Applicant: THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK
    Inventors: Andrew C. Kruegel, Adam Henke, Madalee M. Gassaway, Marie-Laure Rives, Jonathan A. Javitch, Dalibor Sames
  • Pasteurella neuraminidase diagnostic methods and immunoassay kit
    Patent number: 6767713
    Abstract: Provided are Pasteurella multocida coding sequences, recombinant DNA molecules, recombinant host cells and methods for making recombinant neuraminidase. Also provided by the present disclosure are immunogenic compositions containing recombinant P. multocida neuraminidase and antigenic peptides derived in sequence therefrom and antibodies specific for P. multocida neuraminidase as well as immunoassays specific for P. multocida neuraminidase, which immunoassays are useful in the detection or diagnosis of P. multocida infections and/or carrier states.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: July 27, 2004
    Assignee: University of Georgia Research Foundation, Inc.
    Inventors: Margie Lee, Susan Sanchez, Adam Henk
  • PASTEURELLA NEURAMINIDASE CODING SEQUENCES, COMPOSITIONS AND DIAGNOSTIC METHODS
    Publication number: 20040072153
    Abstract: Provided are Pasteurella multocida coding sequences, recombinant DNA molecules, recombinant host cells and methods for making recombinant neuraminidase. Also provided by the present disclosure are immunogenic compositions containing recombinant P. multocida neuraminidase and antigenic peptides derived in sequence therefrom and antibodies specific for P. multocida neuraminidase as well as immunoassays specific for P. multocida neuraminidase, which immunoassays are useful in the detection or diagnosis of P. multocida infections and/or carrier states.
    Type: Application
    Filed: September 21, 1999
    Publication date: April 15, 2004
    Inventors: MARGIE LEE, SUSAN SANCHEZ, ADAM HENK
  • Pasteurella neuraminidase coding sequences and diagnostic methods
    Patent number: 6271011
    Abstract: Provided are Pasteurella multocida coding sequences, recombinant DNA molecules, recombinant host cells and methods for making recombinant neuraminidase. Also provided by the present disclosure are immunogenic compositions containing recombinant P. multocida neuraminidase and antigenic peptides derived in sequence therefrom and antibodies specific for P. multocida neuraminidase as well as immunoassays specific for P. multocida neuraminidase, which immunoassays are useful in the detection or diagnosis of P. multocida infections and/or carrier states.
    Type: Grant
    Filed: September 21, 1999
    Date of Patent: August 7, 2001
    Assignee: The University of Georgia Research Foundation, Inc.
    Inventors: Margie Lee, Susan Sanchez, Adam Henk